Consultant Medical Oncologist
IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
Bologna, Emilia-Romagna, Italy
Emanuela Palmerini is a medical oncologist, and has been on staff in the Musculoskeletal Oncology Department, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, since March 2005. Her clinical interests are bone and soft tissue tumors.
She is the academic leader of the Chemotherapy Unit phase I-III clinical trials in sarcomas and has acted as PI or co-I in more than 20 clinical trials in the treatment of sarcoma. She collaborates with the IRCCS Istituto Ortopedico Rizzoli Research Laboratories pioneering new treatments for these rare tumors, and with the Cell Therapy Laboratory and the Hemolymphopathology Laboratory at the Institute of Hematology Seragnoli in Bologna, studying the role of tumor microenvironment and immunotherapy in sarcomas.
She has been recognized several awards for sarcoma research and 4 research grants, to identify new treatments in Breast Cancer (1 year), Ewing (3 year), Synovial sarcoma (1 year) and Osteosarcoma (1 year). She has been invited faculty in numerous sarcoma courses (e.g. Musculoskeletal Tumor Course at IRCCS Istituto Ortopedico Rizzoli, San Jose, Costa Rica; Buenos Aires, Argentina; Cluj Nopoca, Romania) and Educational Lecturer at ASCO Annual Meeting in 2018. In 2018 she obtained PhD in Oncology, Pathology, Hematology at Bologna University.
In May 2021 she was appointed the National Academic Qualification as Full Professor – Hematology, Oncology and Rheumatology (06/D3). She is member of several scientific societies including ASCO, ESMO, CTOS, EORTC, SELNET. In 2019, she was elected to the board of Director at European Musculoskeletal Oncology Society (EMSOS) and to the European Organization of Cancer Research (EORTC) Bone Sarcoma Clinical Trial Working Group. From 2021 she has been a member of the Euro-Ewing Consortium Radiation Oncology Working Group, and co-Chair of the European Osteosarcoma Consortium.
She has authored or co-authored more than 140 publications, 7 book chapters and 3 musculoskeletal tumors atlas (H-index 50 Google Scholar).
Disclosure information not submitted.
Session 6: Sarcoma of the Year: Small Round Blue Cell Tumor
Friday, November 3, 2023
10:00 AM – 11:00 AM